Financial Performance: SPLIL's revenue, profit margins, and earnings per share directly influence investor sentiment. Strong financials often lead to increased demand and a higher stock price.

Market Sentiment: Overall investor confidence and risk appetite impact all stocks. Positive market sentiment typically pushes prices up, while negative sentiment can cause them to fall.

Industry Trends: Performance of the broader pharmaceutical industry, including growth rates, regulatory changes, and technological advancements, affects SPLIL's valuation.

Company News: Major announcements like new product launches, clinical trial results, acquisitions, or collaborations can significantly alter the stock price.

Economic Factors: Macroeconomic conditions such as inflation, interest rates, and economic growth influence investor behavior and company profitability, impacting SPLIL's stock price.

Regulatory Environment: Government regulations pertaining to drug approvals, pricing policies, and healthcare reforms directly affect SPLIL's operations and future prospects.

Competition: The competitive landscape, including the presence of established players, emerging biosimilars, and generic drug manufacturers, impacts SPLIL's market share and profitability.

Global Events: International events such as geopolitical tensions, trade wars, and pandemics can disrupt supply chains, impact demand, and influence SPLIL's stock price.

Investor Relations: Company communication with investors through earnings calls, investor presentations, and public disclosures plays a crucial role in shaping market perception.